A Rare Side Effect due to TNF-Alpha Blocking Agent: Acute Pleuropericarditis with Adalimumab

Tumor necrosis factor-alpha antagonism is an important treatment strategy in patients with rheumatoid arthritis, psoriatic arthritis, vasculitis, and ankylosing spondylitis. Adalimumab is one of the well-known tumor necrosis factor-alpha blocking agents. There are several side effects reported in pa...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Ozkan, Hakan, Cetinkaya, Ahmet Seckin, Yildiz, Tekin, Bozat, Tahsin
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2013
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3732623/
https://ncbi.nlm.nih.gov/pubmed/23970991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/985914
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items